MFIMFI
IPXL

Mesirow Financial Investment Management - Fixed Income’s Impax Laboratories, Inc. IPXL Stock Holding History

Mesirow Financial Investment Management - Fixed Income’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-555,086
Closed -$16M – 293
2016
Q2 		$16M Buy
+555,086
New +$18.1M 0.93% 68

Other funds holding IPXL

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Mesirow Financial Investment Management - Fixed Income's IPXL Position: Q3 2016 in Review

Mesirow Financial Investment Management - Fixed Income sold out of Impax Laboratories, Inc. (IPXL) in Q3 2016, closing a stake of 555,086 shares — an estimated $16M sold.

Mesirow Financial Investment Management - Fixed Income first reported a position in IPXL in Q2 2016 and held it in 1 quarter. The position peaked at $16M in Q2 2016. 196 funds tracked by Wall St. Rank hold IPXL as of Q3 2016.

  • Mesirow Financial Investment Management - Fixed Income reported no remaining Impax Laboratories, Inc. position as of Q3 2016 after selling out during the quarter.
  • Mesirow Financial Investment Management - Fixed Income sold 555,086 Impax Laboratories, Inc. shares in Q3 2016, an estimated $16M.
  • Mesirow Financial Investment Management - Fixed Income first reported a position in Impax Laboratories, Inc. in Q2 2016 and held it in 1 quarter.
  • Mesirow Financial Investment Management - Fixed Income's Impax Laboratories, Inc. position peaked at $16M in Q2 2016.
  • 196 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q3 2016.

Based on Mesirow Financial Investment Management - Fixed Income's 13F filing for Q3 2016, filed 28 Oct 2016.